Cancer becomes far more dangerous when it spreads from its original location to other parts of the body. This process is ...

New studies from UCL and Newcastle University reveal how gut health and simple treatments like aspirin could be the keys to ...

Aspirin reduces the risk of colon cancer recurrence after surgery, but only in patients with a specific genetic marker ...

The 4,000-year-old drug, most commonly used to treat pain, prevents certain tumours from forming and spreading across the body – findings that are already changing health policies.

New research suggests aspirin may reduce cancer spread in some cases, but experts warn of bleeding risks and urge medical ...

Dr Alfred Jatho, the head of community cancer services at Uganda Cancer Institute in charge of prevention, said the use of ...

Growing evidence reveals that aspirin may influence key mechanisms of tumor development, reinforcing its importance in modern ...

“Aspirin is a drug that is readily available globally and extremely inexpensive compared to many modern cancer drugs, which is very positive,” says Anna Martling.

One of the world's oldest medicines may have a powerful new purpose. A growing body of clinical evidence suggests that aspirin, the common painkiller with roots stretching back 4,000 years, can ...

A daily regimen of low dose aspirin probably does not significantly reduce the risk of colorectal cancer but may increase the risk of bleeding in the brain area, according to a large-scale analysis of ...

Aspirin (ASA) likely results in little to no difference in colorectal cancer (CRC) incidence at a follow-up of 5 years to less than 15 years, a review by Chinese investigators reported in The Cochrane ...

Doctors have long recommended daily aspirin for years as a low-cost protection against cancers of the lower bowel. New research suggests there might not be a dependable benefit for low-risk patients.